AT A GLANCE
- Start with the original study rather than a headline.
- Identify whether the evidence comes from cells, animals or people.
- Read limitations and adverse events alongside positive findings.
Write down the question first
Before opening a paper, decide what you want to know. Material identity, a proposed mechanism and a clinical outcome are different questions. A study can be well designed and still be the wrong source for your question. This simple distinction saves more time than collecting a long list of loosely related citations.
Identify the experimental setting
Cell and animal studies investigate questions that do not directly establish outcomes in people. Clinical research then evaluates defined questions in human participants. The FDA’s explanation of drug development separates these stages and explains why preclinical work cannot substitute for human studies. [1]
- 01Question
- 02Material and model
- 03Comparator and endpoint
- 04Bounded conclusion
Conceptual reading guide — not a biological pathway or an efficacy comparison.
Find the comparison and the outcome
Ask what the experimental group was compared with and what the researchers measured. A change in a laboratory marker is different from a symptom improvement. An outcome chosen before the study is different from an exploratory observation. Keeping these distinctions in your notes makes it harder for a dramatic summary to outrun the evidence.
Keep a compact evidence record
For every paper, record the exact material, model, comparator, endpoint and main limitation. Add the source URL so another reader can check your interpretation. If evaluating a product, keep its analytical documents in a separate section. A publication explains a study; a batch report describes a supplied batch. Neither document automatically replaces the other.
| Field | What to write | Common mistake |
|---|---|---|
| Material | Exact tested identity | Using only a trade name |
| Model | Cells, animals or participants | Assuming human relevance |
| Comparator | Control condition | Ignoring baseline effects |
| Endpoint | What was measured | Replacing it with a broader benefit |
| Limitation | What remains unanswered | Treating absence of evidence as proof |
Questions, answered.
Is a peer-reviewed paper enough to prove a product claim?
Not automatically. Its material, methods and outcome must actually support the claim being made.
Should I ignore animal studies?
No. They can be informative for defined scientific questions, while their limits remain important.
Sources & further reading
- FDA · Clinical research
Primary regulatory explanation of the clinical research stage.
